News – Page 1136 – Endpoints News

SIGN UP

Experts fret over a new hiring freeze at the FDA. Will the fallout be toxic to drug reviews?

9 years ago

Eisai plots new drug applications in US, Europe and China after Lenvima scores in head-to-head liver cancer study

9 years ago

Fighting a generic onslaught, Novartis adds CAR-T to its growing list of late-stage blockbusters

9 years ago

Novartis’ biotech shopping spree stays focused on the low-budget specials of the day

9 years ago

Regeneron buys its HQ site for $720M; Fast-growing Seattle Genetics plans 200 more hires this year

9 years ago

Ex-Mela chief Gulfo joins the list of would-be FDA commish candidates, color-coded drug approval plan in hand

9 years ago

A biotech billionaire grabs microcap GenVec and its gene vector tech in buyout

9 years ago

Women are gaining more board seats in biotech, but real change is happening at a snail's pace

9 years ago

An upstart immunotherapy biotech emerges from stealth mode with big love for Kendall Square

9 years ago

Banned from Twitter, Martin Shkreli whips up a new online tirade in response to a mocking dig from PhRMA chief

9 years ago

Facing a deepening political crisis, PhRMA launches a major counterattack against its legion of critics

9 years ago

Bizarre takeover bid is dropped; Merck KGaA in licensing pact with Domain

9 years ago

Struggling Marinus gets a bump out of a positive PhII snapshot

9 years ago

Deep in talks with J&J, Actelion’s flagship drug cruises past a pivotal trial failure

9 years ago

Ovid adds $26M to its coffers as Takeda deal closes, building a war chest for pipeline construction work

9 years ago

After repeated setbacks on the checkpoint front, Bristol-Myers scores a $625M payout from Merck to settle patent ...

9 years ago

Libertarian ideas on FDA deregulation threaten biotech; It's time for some real power to reform drug prices, ...

9 years ago

Pfizer signs up for match-making service; Investors tell Sanofi: Make a deal, now

9 years ago

How Takeda won a $5.2B bidding war — against itself

9 years ago

The FDA’s cautionary Hall of Shame: 22 ‘breakthrough’ drugs that suddenly crashed in PhIII

9 years ago

Francis Collins gets a reprieve, held over as NIH chief under Trump — for now

9 years ago

Bristol-Myers staggered by a stunning checkpoint setback, hands Merck a free pass on frontline lung cancer combo

9 years ago

Synergy bags an FDA OK for constipation therapy Trulance in the lead up to an sNDA

9 years ago

Cytori bags Azaya drugs in asset purchase; Woodford offers a mea culpa on Northwest Bio

9 years ago

First page Previous page 1133 1134 113511361137 1138 1139 Next page Last page